Zeev Estrov

Publications

• At High Levels, Constitutively Activated STAT3 Induces Apoptosis of Chronic Lymphocytic Leukemia Cells
  Journal of Immunology (Baltimore, Md. : 1950). May, 2016  |   Pubmed ID: 27076684
• Autoimmune Cytopenias in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib
  Haematologica. Jun, 2016  |   Pubmed ID: 27013651
• Clinical Implications of TP53 Mutations in Myelodysplastic Syndromes Treated with Hypomethylating Agents
  Oncotarget. Mar, 2016  |   Pubmed ID: 26871476
• Philadelphia-positive Dimorphic Blasts in Mixed-phenotype Acute Leukemia with TET2 Mutation
  American Journal of Hematology. Jun, 2016  |   Pubmed ID: 26799924
• Clofarabine Plus Low-Dose Cytarabine Is As Effective As and Less Toxic Than Intensive Chemotherapy in Elderly AML Patients
  Clinical Lymphoma, Myeloma & Leukemia. Mar, 2016  |   Pubmed ID: 26752456
• Impact of BCR-ABL Transcript Type on Outcome in Patients with Chronic-phase CML Treated with Tyrosine Kinase Inhibitors
  Blood. Mar, 2016  |   Pubmed ID: 26729897
• Metabolism Pathways in Chronic Lymphocytic Leukemia
  Leukemia & Lymphoma. Apr, 2016  |   Pubmed ID: 26643954
• β2 -microglobulin Normalization Within 6 Months of Ibrutinib-based Treatment is Associated with Superior Progression-free Survival in Patients with Chronic Lymphocytic Leukemia
  Cancer. Feb, 2016  |   Pubmed ID: 26588193
• Minimal Residual Disease Assessed by Multi-parameter Flow Cytometry is Highly Prognostic in Adult Patients with Acute Lymphoblastic Leukaemia
  British Journal of Haematology. Feb, 2016  |   Pubmed ID: 26492205
• Synchronous Del5q Myelodysplastic Syndrome (del5qMDS) and Adult B-cell Acute Lymphoblastic Leukemia (B-ALL) with TET2 and TP53 Mutations
  American Journal of Hematology. Mar, 2016  |   Pubmed ID: 26437693
• Chronic Lymphocytic Leukemia and Myeloproliferative Neoplasms Concurrently Diagnosed: Clinical and Biological Characteristics
  Leukemia & Lymphoma. May, 2016  |   Pubmed ID: 26402369
• Secondary Solid Tumors and Lymphoma in Patients with Essential Thrombocythemia and Polycythemia Vera - Single Center Experience
  Leukemia & Lymphoma. 2016  |   Pubmed ID: 25904378
• Relapsed Refractory BRAF-Negative, IGHV4-34-Positive Variant of Hairy Cell Leukemia: A Distinct Entity?
  Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Mar, 2016  |   Pubmed ID: 24982452
• DNMT3A, TET2, and JAK2 Mutations in Polycythemia Vera Following Long-term Remission of Secondary Acute Myeloid Leukemia
  Leukemia & Lymphoma. Dec, 2015  |   Pubmed ID: 26700872
• Combination of Hyper-CVAD with Ponatinib As First-line Therapy for Patients with Philadelphia Chromosome-positive Acute Lymphoblastic Leukaemia: a Single-centre, Phase 2 Study
  The Lancet. Oncology. Nov, 2015  |   Pubmed ID: 26432046
• Acute Myeloid Leukemia with MYC Rearrangement and JAK2 V617F Mutation
  Cancer Genetics. Nov, 2015  |   Pubmed ID: 26382622
• Long-term Follow-up of a Phase 2 Study of Chemotherapy Plus Dasatinib for the Initial Treatment of Patients with Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
  Cancer. Dec, 2015  |   Pubmed ID: 26308885
• Epstein-Barr Virus MicroRNAs Are Expressed in Patients with Chronic Lymphocytic Leukemia and Correlate with Overall Survival
  EBioMedicine. Jun, 2015  |   Pubmed ID: 26288818
• Fludarabine, Cyclophosphamide, and Multiple-dose Rituximab As Frontline Therapy for Chronic Lymphocytic Leukemia
  Cancer. Nov, 2015  |   Pubmed ID: 26218678
• Complex Karyotype is a Stronger Predictor Than Del(17p) for an Inferior Outcome in Relapsed or Refractory Chronic Lymphocytic Leukemia Patients Treated with Ibrutinib-based Regimens
  Cancer. Oct, 2015  |   Pubmed ID: 26193999
• Association of Lymphoid Malignancies and Philadelphia-chromosome Negative Myeloproliferative Neoplasms: Clinical Characteristics, Therapy and Outcome
  Leukemia Research. Aug, 2015  |   Pubmed ID: 26012362
• Disseminated Histoplasmosis As Pseudo Richter's Transformation in a Patient with Chronic Lymphocytic Leukemia
  American Journal of Hematology. Aug, 2015  |   Pubmed ID: 25850565
• Outcomes of Patients With Chronic Lymphocytic Leukemia and Richter's Transformation After Transplantation Failure
  Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. May, 2015  |   Pubmed ID: 25847930
• Meir Wetzler, MD
  Cancer. Jul, 2015  |   Pubmed ID: 25832851
• The Addition of CD20 Monoclonal Antibodies to Lenalidomide Improves Response Rates and Survival in Relapsed/refractory Patients with Chronic Lymphocytic Leukaemia Relative to Lenalidomide Monotherapy - the MD Anderson Cancer Center Experience
  British Journal of Haematology. Mar, 2015  |   Pubmed ID: 25824652
• Durable Remission with Rituximab in a Patient with an Unusual Variant of Castleman's Disease with Myelofibrosis-TAFRO Syndrome
  American Journal of Hematology. Nov, 2015  |   Pubmed ID: 25808231
• Aberrant LPL Expression, Driven by STAT3, Mediates Free Fatty Acid Metabolism in CLL Cells
  Molecular Cancer Research : MCR. May, 2015  |   Pubmed ID: 25733697
• High Fluorescence in Situ Hybridization Percentage of Deletion 11q in Patients with Chronic Lymphocytic Leukemia is an Independent Predictor of Adverse Outcome
  American Journal of Hematology. Jun, 2015  |   Pubmed ID: 25683856
• Outcomes of Patients with Chronic Lymphocytic Leukemia After Discontinuing Ibrutinib
  Blood. Mar, 2015  |   Pubmed ID: 25573991
• Phase I/II Trial of the Combination of Midostaurin (PKC412) and 5-azacytidine for Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome
  American Journal of Hematology. Apr, 2015  |   Pubmed ID: 25530214
• Very High Levels of Lactate Dehydrogenase at Diagnosis Predict Central Nervous System Relapse in Acute Promyelocytic Leukaemia
  British Journal of Haematology. May, 2015  |   Pubmed ID: 25413673
• Phase II Study of Methotrexate, Vincristine, Pegylated-asparaginase, and Dexamethasone (MOpAD) in Patients with Relapsed/refractory Acute Lymphoblastic Leukemia
  American Journal of Hematology. Feb, 2015  |   Pubmed ID: 25368968
• Second Cancers in Patients with Chronic Lymphocytic Leukemia Who Received Frontline Fludarabine, Cyclophosphamide and Rituximab Therapy: Distribution and Clinical Outcomes
  Leukemia & Lymphoma. Jun, 2015  |   Pubmed ID: 25308294
• Incidence of and Risk Factors for Involvement of the Central Nervous System in Acute Myeloid Leukemia
  Leukemia & Lymphoma. May, 2015  |   Pubmed ID: 25110819
• Myeloid Neoplasms After Breast Cancer: "therapy-related" Not an Independent Poor Prognostic Factor
  Leukemia & Lymphoma. Apr, 2015  |   Pubmed ID: 25048874
• Requirement for Ssbp2 in Hematopoietic Stem Cell Maintenance and Stress Response
  Journal of Immunology (Baltimore, Md. : 1950). Nov, 2014  |   Pubmed ID: 25238756
• Clinical Significance of Microcytosis in Patients with Primary Myelofibrosis
  Leukemia Research. Oct, 2014  |   Pubmed ID: 25217891
• Isolated Mesenteric CD20-positive Myeloid Sarcoma
  Clinical Lymphoma, Myeloma & Leukemia. Dec, 2014  |   Pubmed ID: 25131853
• FCR and Bevacizumab Treatment in Patients with Relapsed Chronic Lymphocytic Leukemia
  Cancer. Nov, 2014  |   Pubmed ID: 25043749
• A Prognostic Model of Therapy-related Myelodysplastic Syndrome for Predicting Survival and Transformation to Acute Myeloid Leukemia
  Clinical Lymphoma, Myeloma & Leukemia. Oct, 2014  |   Pubmed ID: 24875590
• STAT3-activated GM-CSFRα Translocates to the Nucleus and Protects CLL Cells from Apoptosis
  Molecular Cancer Research : MCR. Sep, 2014  |   Pubmed ID: 24836891
• Stimulation of the B-cell Receptor Activates the JAK2/STAT3 Signaling Pathway in Chronic Lymphocytic Leukemia Cells
  Blood. Jun, 2014  |   Pubmed ID: 24778152
• Treatment with FLT3 Inhibitor in Patients with FLT3-mutated Acute Myeloid Leukemia is Associated with Development of Secondary FLT3-tyrosine Kinase Domain Mutations
  Cancer. Jul, 2014  |   Pubmed ID: 24737502
• Eradication of Bone Marrow Minimal Residual Disease May Prompt Early Treatment Discontinuation in CLL
  Blood. Jun, 2014  |   Pubmed ID: 24705492
• Interleukin-7 Receptor-α Gene Mutations Are Not Detected in Adult T-cell Acute Lymphoblastic Leukemia
  Cancer Medicine. Jun, 2014  |   Pubmed ID: 24678068
• Correlation Between FDG/PET, Histology, Characteristics, and Survival in 332 Patients with Chronic Lymphoid Leukemia
  Blood. May, 2014  |   Pubmed ID: 24615780
• Statin and Aspirin Use is Associated with Improved Outcome of FCR Therapy in Relapsed/refractory Chronic Lymphocytic Leukemia
  Blood. Feb, 2014  |   Pubmed ID: 24578497
• Interaction Between Myelomonocytic and Lymphoid Cells in a Patient with Acute Myelomonocytic Leukemia and Chronic Lymphocytic Leukemia
  Leukemia & Lymphoma. Jun, 2014  |   Pubmed ID: 23987820
• Personalized Medicine in CLL: Current Status and Future Perspectives
  Cancer Letters. Sep, 2014  |   Pubmed ID: 23879961
• Atypical Chronic Lymphocytic Leukemia with Polyglandular Autoimmune Endocrinopathy Type II: a Complex Profile
  Leukemia & Lymphoma. Apr, 2014  |   Pubmed ID: 23829280
• The PI3-kinase Delta Inhibitor Idelalisib (GS-1101) Targets Integrin-mediated Adhesion of Chronic Lymphocytic Leukemia (CLL) Cell to Endothelial and Marrow Stromal Cells
  PloS One. 2013  |   Pubmed ID: 24376763
• Detection of Dormant Chronic Myeloid Leukemia Clones in the Bone Marrow of Patients in Complete Molecular Remission
  Clinical Lymphoma, Myeloma & Leukemia. Dec, 2013  |   Pubmed ID: 24060288
• Targeting Inflammatory Pathways in Chronic Lymphocytic Leukemia
  Critical Reviews in Oncology/hematology. Dec, 2013  |   Pubmed ID: 23941728
• Small Molecule ErbB Inhibitors Decrease Proliferative Signaling and Promote Apoptosis in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
  PloS One. 2013  |   Pubmed ID: 23936456
• Clofarabine, Idarubicin, and Cytarabine (CIA) As Frontline Therapy for Patients ≤60 Years with Newly Diagnosed Acute Myeloid Leukemia
  American Journal of Hematology. Nov, 2013  |   Pubmed ID: 23877926
• Detection of MRD May Predict the Outcome of Patients with Philadelphia Chromosome-positive ALL Treated with Tyrosine Kinase Inhibitors Plus Chemotherapy
  Blood. Aug, 2013  |   Pubmed ID: 23836561
• Prognostic Value of MiR-155 in Individuals with Monoclonal B-cell Lymphocytosis and Patients with B Chronic Lymphocytic Leukemia
  Blood. Sep, 2013  |   Pubmed ID: 23821659
• CD4(-)/CD8(-) Variant of T-cell Large Granular Lymphocytic Leukemia or Hepatosplenic T-cell Lymphoma: a Clinicopathologic Dilemma
  Clinical Lymphoma, Myeloma & Leukemia. Oct, 2013  |   Pubmed ID: 23800602
• Molecular Analysis of Patients with Polycythemia Vera or Essential Thrombocythemia Receiving Pegylated Interferon α-2a
  Blood. Aug, 2013  |   Pubmed ID: 23782935
• Acquisition of Cytogenetic Abnormalities in Patients with IPSS Defined Lower-risk Myelodysplastic Syndrome is Associated with Poor Prognosis and Transformation to Acute Myelogenous Leukemia
  American Journal of Hematology. Oct, 2013  |   Pubmed ID: 23760779
• Signal Transducer and Activator of Transcription-3 Induces MicroRNA-155 Expression in Chronic Lymphocytic Leukemia
  PloS One. 2013  |   Pubmed ID: 23750211
• Randomized Open-label Phase II Study of Decitabine in Patients with Low- or Intermediate-risk Myelodysplastic Syndromes
  Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Jul, 2013  |   Pubmed ID: 23733767
• Signal Transducer and Activator of Transcription (STAT)-3 Regulates MicroRNA Gene Expression in Chronic Lymphocytic Leukemia Cells
  Molecular Cancer. 2013  |   Pubmed ID: 23725032
• Salvage Therapy Using FLT3 Inhibitors May Improve Long-term Outcome of Relapsed or Refractory AML in Patients with FLT3-ITD
  British Journal of Haematology. Jun, 2013  |   Pubmed ID: 23530930
• Prognostic Impact of RAS Mutations in Patients with Myelodysplastic Syndrome
  American Journal of Hematology. May, 2013  |   Pubmed ID: 23512829
• Spontaneous Remission of Chemo-immunotherapy Related, Non-transplant Epstein-Barr Virus-associated Lymphoproliferative Disorder in a Patient with Chronic Lymphocytic Leukemia
  Leukemia & Lymphoma. Nov, 2013  |   Pubmed ID: 23387894
• Prognostic Implications and Clinical Characteristics Associated with Bone Marrow Fibrosis in Patients with Myelofibrosis
  Leukemia & Lymphoma. Nov, 2013  |   Pubmed ID: 23343175
• Chronic Lymphocytic Leukemia with Central Nervous System Involvement: a High-risk Disease?
  Clinical Lymphoma, Myeloma & Leukemia. Jun, 2013  |   Pubmed ID: 23332395
• Central Nervous System Richter's Transformation and Parvovirus B19 Infection
  Leukemia & Lymphoma. Sep, 2013  |   Pubmed ID: 23320889
• Is Acute Myeloid Leukemia a Liquid Tumor?
  International Journal of Cancer. Aug, 2013  |   Pubmed ID: 23280377
• The Significance of Spliceosome Mutations in Chronic Lymphocytic Leukemia
  Leukemia & Lymphoma. Jul, 2013  |   Pubmed ID: 23270583
• Azacitidine in Fludarabine-refractory Chronic Lymphocytic Leukemia: a Phase II Study
  Clinical Lymphoma, Myeloma & Leukemia. Jun, 2013  |   Pubmed ID: 23265768
• Epstein-Barr Virus-induced CD30-positive Diffuse Large B-cell Lymphoma in a Patient with Mixed-phenotypic Leukemia Treated with Clofarabine
  Clinical Lymphoma, Myeloma & Leukemia. Jun, 2013  |   Pubmed ID: 23246163
• Ocular Granulocytic Sarcoma: a Case Report and Literature Review of Ocular Extramedullary Acute Myeloid Leukemia
  Clinical Lymphoma, Myeloma & Leukemia. Feb, 2013  |   Pubmed ID: 23017332
• Deletion of TAK1 in the Myeloid Lineage Results in the Spontaneous Development of Myelomonocytic Leukemia in Mice
  PloS One. 2012  |   Pubmed ID: 23251462
• Therapeutic Effects of Ruxolitinib in Patients with Myelofibrosis Without Clinically Significant Splenomegaly
  Blood. Sep, 2012  |   Pubmed ID: 23019204
• Heterodimeric JAK-STAT Activation As a Mechanism of Persistence to JAK2 Inhibitor Therapy
  Nature. Sep, 2012  |   Pubmed ID: 22820254
• Long-term Outcomes of 107 Patients with Myelofibrosis Receiving JAK1/JAK2 Inhibitor Ruxolitinib: Survival Advantage in Comparison to Matched Historical Controls
  Blood. Aug, 2012  |   Pubmed ID: 22718840
• A Phase II Study of Lenalidomide Alone in Relapsed/refractory Acute Myeloid Leukemia or High-risk Myelodysplastic Syndromes with Chromosome 5 Abnormalities
  Clinical Lymphoma, Myeloma & Leukemia. Oct, 2012  |   Pubmed ID: 22579233
• Phase I-II Study of Bendamustine in Patients with Acute Leukemia and High Risk Myelodysplastic Syndrome
  Clinical Lymphoma, Myeloma & Leukemia. Jun, 2012  |   Pubmed ID: 22578814
• Therapy with the Histone Deacetylase Inhibitor Pracinostat for Patients with Myelofibrosis
  Leukemia Research. Sep, 2012  |   Pubmed ID: 22475363
• Phase 2 Study of the JAK Kinase Inhibitor Ruxolitinib in Patients with Refractory Leukemias, Including Postmyeloproliferative Neoplasm Acute Myeloid Leukemia
  Blood. May, 2012  |   Pubmed ID: 22422826
• Final Results of the Phase II Study of Rabbit Anti-thymocyte Globulin, Ciclosporin, Methylprednisone, and Granulocyte Colony-stimulating Factor in Patients with Aplastic Anaemia and Myelodysplastic Syndrome
  British Journal of Haematology. May, 2012  |   Pubmed ID: 22360602
• Acute Lymphoblastic Leukemia Arising in Post-polycythemic Myelofibrosis: a Rare Entity
  Leukemia & Lymphoma. Sep, 2012  |   Pubmed ID: 22303899
• Phase II Study of the Histone Deacetylase Inhibitor Panobinostat (LBH589) in Patients with Low or Intermediate-1 Risk Myelodysplastic Syndrome
  American Journal of Hematology. Jan, 2012  |   Pubmed ID: 22072492
• A Randomized Study of 2 Dose Levels of Intravenous Clofarabine in the Treatment of Patients with Higher-risk Myelodysplastic Syndrome
  Cancer. Feb, 2012  |   Pubmed ID: 21751197
• Implications of Discrepancy in Morphologic Diagnosis of Myelodysplastic Syndrome Between Referral and Tertiary Care Centers
  Blood. Oct, 2011  |   Pubmed ID: 21868570
• Treatment with Lenalidomide Modulates T-cell Immunophenotype and Cytokine Production in Patients with Chronic Lymphocytic Leukemia
  Cancer. Sep, 2011  |   Pubmed ID: 21858802
• Frontline Chemoimmunotherapy with Fludarabine, Cyclophosphamide, Alemtuzumab, and Rituximab for High-risk Chronic Lymphocytic Leukemia
  Blood. Aug, 2011  |   Pubmed ID: 21750315
• Cross-talk Between Chronic Lymphocytic Leukemia Cells and Bone Marrow Endothelial Cells: Role of Signal Transducer and Activator of Transcription 3
  Human Pathology. Dec, 2011  |   Pubmed ID: 21733558
• Transformation of Human Mesenchymal Cells and Skin Fibroblasts into Hematopoietic Cells
  PloS One. 2011  |   Pubmed ID: 21731684
• 在完全缓解后诱导急性髓系白血病患者的细胞遗传学异常的持久性： 预后意义和异基因造血干细胞移植方面的潜在作用。
  Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Jun, 2011  |   Pubmed ID: 21555694
• Bone Marrow Stroma-secreted Cytokines Protect JAK2(V617F)-mutated Cells from the Effects of a JAK2 Inhibitor
  Cancer Research. Jun, 2011  |   Pubmed ID: 21512135
• Evaluating the Serial Use of the Myelofibrosis Symptom Assessment Form for Measuring Symptomatic Improvement: Performance in 87 Myelofibrosis Patients on a JAK1 and JAK2 Inhibitor (INCB018424) Clinical Trial
  Cancer. Nov, 2011  |   Pubmed ID: 21480207
• STAT-3 Activates NF-kappaB in Chronic Lymphocytic Leukemia Cells
  Molecular Cancer Research : MCR. Apr, 2011  |   Pubmed ID: 21364020
• A Phase 1-2 Study of a Farnesyltransferase Inhibitor, Tipifarnib, Combined with Idarubicin and Cytarabine for Patients with Newly Diagnosed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome
  Cancer. Mar, 2011  |   Pubmed ID: 20960519
• Ubiquitin-proteasome System Profiling in Acute Leukemias and Its Clinical Relevance
  Leukemia Research. Apr, 2011  |   Pubmed ID: 20951430
• The Synthetic Heat Shock Protein 90 (Hsp90) Inhibitor EC141 Induces Degradation of Bcr-Abl P190 Protein and Apoptosis of Ph-positive Acute Lymphoblastic Leukemia Cells
  Investigational New Drugs. Dec, 2011  |   Pubmed ID: 20533075
• Kit Inhibitor APcK110 Extends Survival in an AML Xenograft Mouse Model
  Investigational New Drugs. Oct, 2011  |   Pubmed ID: 20517635
• Preclinical Characterization of Atiprimod, a Novel JAK2 AND JAK3 Inhibitor
  Investigational New Drugs. Oct, 2011  |   Pubmed ID: 20372971
• Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis
  The New England Journal of Medicine. Sep, 2010  |   Pubmed ID: 20843246
• Stat3 Activates the Receptor Tyrosine Kinase Like Orphan Receptor-1 Gene in Chronic Lymphocytic Leukemia Cells
  PloS One. 2010  |   Pubmed ID: 20686606
• Recurrent Expression Signatures of Cytokines and Chemokines Are Present and Are Independently Prognostic in Acute Myelogenous Leukemia and Myelodysplasia
  Blood. Nov, 2010  |   Pubmed ID: 20679526
• Survival Outcomes for Clonal Evolution in Chronic Myeloid Leukemia Patients on Second Generation Tyrosine Kinase Inhibitor Therapy
  Cancer. Jun, 2010  |   Pubmed ID: 20499401
• Genome-wide DNA Methylation Profiling of Chronic Lymphocytic Leukemia Allows Identification of Epigenetically Repressed Molecular Pathways with Clinical Impact
  Epigenetics. Aug, 2010  |   Pubmed ID: 20484983
• Homologous Recombination As a Resistance Mechanism to Replication-induced Double-strand Breaks Caused by the Antileukemia Agent CNDAC
  Blood. Sep, 2010  |   Pubmed ID: 20479284
• Oral Clofarabine in the Treatment of Patients with Higher-risk Myelodysplastic Syndrome
  Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Jun, 2010  |   Pubmed ID: 20421540
• Circulating Ki-67 Index in Plasma As a Biomarker and Prognostic Indicator in Chronic Lymphocytic Leukemia
  Leukemia Research. Oct, 2010  |   Pubmed ID: 20362333
• The Leukemia Stem Cell
  Cancer Treatment and Research. 2010  |   Pubmed ID: 20306242
• Phase I/II Study of Combination Therapy with Sorafenib, Idarubicin, and Cytarabine in Younger Patients with Acute Myeloid Leukemia
  Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Apr, 2010  |   Pubmed ID: 20212254
• STAT3 is Constitutively Phosphorylated on Serine 727 Residues, Binds DNA, and Activates Transcription in CLL Cells
  Blood. Apr, 2010  |   Pubmed ID: 20154216
• Phase 2 Study of CEP-701, an Orally Available JAK2 Inhibitor, in Patients with Primary or Post-polycythemia Vera/essential Thrombocythemia Myelofibrosis
  Blood. Feb, 2010  |   Pubmed ID: 20008298
• Clinical Correlation of Circulating Heat Shock Protein 70 in Acute Leukemia
  Leukemia Research. May, 2010  |   Pubmed ID: 19800118
• Circulating Ki-67 Protein in Plasma As a Biomarker and Prognostic Indicator of Acute Lymphoblastic Leukemia
  Leukemia Research. Feb, 2010  |   Pubmed ID: 19679351
• Pegylated Interferon Alfa-2a Yields High Rates of Hematologic and Molecular Response in Patients with Advanced Essential Thrombocythemia and Polycythemia Vera
  Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Nov, 2009  |   Pubmed ID: 19826111
• Stem Cells and Somatic Cells: Reprogramming and Plasticity
  Clinical Lymphoma & Myeloma. 2009  |   Pubmed ID: 19778860
• 多样的骨髓基质干细胞从自发和药物诱导细胞凋亡保护搭建的单元格： 发展的可靠和可重现的制度，以评估基质细胞粘附介导的耐药性。
  Blood. Nov, 2009  |   Pubmed ID: 19762485
• The Use of Nilotinib or Dasatinib After Failure to 2 Prior Tyrosine Kinase Inhibitors: Long-term Follow-up
  Blood. Nov, 2009  |   Pubmed ID: 19729517
• Cytogenetic Abnormalities in Essential Thrombocythemia at Presentation and Transformation
  International Journal of Hematology. Nov, 2009  |   Pubmed ID: 19728024
• Proteasome Enzymatic Activities in Plasma As Risk Stratification of Patients with Acute Myeloid Leukemia and Advanced-stage Myelodysplastic Syndrome
  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Jun, 2009  |   Pubmed ID: 19458051
• Phase 1-2a Multicenter Dose-escalation Study of Ezatiostat Hydrochloride Liposomes for Injection (Telintra, TLK199), a Novel Glutathione Analog Prodrug in Patients with Myelodysplastic Syndrome
  Journal of Hematology & Oncology. 2009  |   Pubmed ID: 19439093
• Kit Inhibitor APcK110 Induces Apoptosis and Inhibits Proliferation of Acute Myeloid Leukemia Cells
  Cancer Research. May, 2009  |   Pubmed ID: 19383925
• Incidence of Extramedullary Disease in Patients with Acute Promyelocytic Leukemia: a Single-institution Experience
  International Journal of Hematology. May, 2009  |   Pubmed ID: 19340529
• Effective Treatment of Acute Promyelocytic Leukemia with All-trans-retinoic Acid, Arsenic Trioxide, and Gemtuzumab Ozogamicin
  Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Feb, 2009  |   Pubmed ID: 19075265
• Circulating Heat Shock Protein 70 and Progression in Patients with Chronic Myeloid Leukemia
  Leukemia Research. Feb, 2009  |   Pubmed ID: 18715642
• Clofarabine Combinations As Acute Myeloid Leukemia Salvage Therapy
  Cancer. Oct, 2008  |   Pubmed ID: 18756533
• A Randomized Study of Clofarabine Versus Clofarabine Plus Low-dose Cytarabine As Front-line Therapy for Patients Aged 60 Years and Older with Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome
  Blood. Sep, 2008  |   Pubmed ID: 18565853
• Phase 1 Study of the Oral Isotype Specific Histone Deacetylase Inhibitor MGCD0103 in Leukemia
  Blood. Aug, 2008  |   Pubmed ID: 18495956
• The JAK Kinase Inhibitor CP-690,550 Suppresses the Growth of Human Polycythemia Vera Cells Carrying the JAK2V617F Mutation
  Cancer Science. Jun, 2008  |   Pubmed ID: 18482053
• Phase 1 Study of XL119, a Rebeccamycin Analog, in Patients with Refractory Hematologic Malignancies
  Cancer. Jul, 2008  |   Pubmed ID: 18473351
• Mechanisms of Antileukemic Activity of the Novel Bcl-2 Homology Domain-3 Mimetic GX15-070 (obatoclax)
  Cancer Research. May, 2008  |   Pubmed ID: 18451169
• Curcumin (diferuloylmethane) Alters the Expression Profiles of MicroRNAs in Human Pancreatic Cancer Cells
  Molecular Cancer Therapeutics. Mar, 2008  |   Pubmed ID: 18347134
• Lenalidomide Induces Complete and Partial Remissions in Patients with Relapsed and Refractory Chronic Lymphocytic Leukemia
  Blood. Jun, 2008  |   Pubmed ID: 18334676
• WP1066, a Novel JAK2 Inhibitor, Suppresses Proliferation and Induces Apoptosis in Erythroid Human Cells Carrying the JAK2 V617F Mutation
  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Feb, 2008  |   Pubmed ID: 18245540
• Mutant FLT3: a Direct Target of Sorafenib in Acute Myelogenous Leukemia
  Journal of the National Cancer Institute. Feb, 2008  |   Pubmed ID: 18230792
• Enzymatic Activity of Circulating Proteasomes Correlates with Clinical Behavior in Patients with Chronic Lymphocytic Leukemia
  Cancer. Mar, 2008  |   Pubmed ID: 18224667
• Phase I-II Study of Oxaliplatin, Fludarabine, Cytarabine, and Rituximab Combination Therapy in Patients with Richter's Syndrome or Fludarabine-refractory Chronic Lymphocytic Leukemia
  Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Jan, 2008  |   Pubmed ID: 18182662
• WP1066 Disrupts Janus Kinase-2 and Induces Caspase-dependent Apoptosis in Acute Myelogenous Leukemia Cells
  Cancer Research. Dec, 2007  |   Pubmed ID: 18056455
• Safety and Clinical Activity of the Combination of 5-azacytidine, Valproic Acid, and All-trans Retinoic Acid in Acute Myeloid Leukemia and Myelodysplastic Syndrome
  Blood. Oct, 2007  |   Pubmed ID: 17596541
• 双表型急性白血病： 一系列病例。
  British Journal of Haematology. Jul, 2007  |   Pubmed ID: 17593028
• Activation of a Novel Bcr/Abl Destruction Pathway by WP1130 Induces Apoptosis of Chronic Myelogenous Leukemia Cells
  Blood. Apr, 2007  |   Pubmed ID: 17202319
• Blockade of Adaptive Defensive Changes in Cholesterol Uptake and Synthesis in AML by the Addition of Pravastatin to Idarubicin + High-dose Ara-C: a Phase 1 Study
  Blood. Apr, 2007  |   Pubmed ID: 17158228
• Phase I/II Study of Subcutaneous Homoharringtonine in Patients with Chronic Myeloid Leukemia Who Have Failed Prior Therapy
  Cancer. Jan, 2007  |   Pubmed ID: 17154172
• Results of a Randomized Study of 3 Schedules of Low-dose Decitabine in Higher-risk Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia
  Blood. Jan, 2007  |   Pubmed ID: 16882708
• Atiprimod Blocks Phosphorylation of JAK-STAT and Inhibits Proliferation of Acute Myeloid Leukemia (AML) Cells
  Leukemia Research. Jan, 2007  |   Pubmed ID: 16828865
• Studying the Right Cell in Acute Myelogenous Leukemia: Dynamic Changes of Apoptosis and Signal Transduction Pathway Protein Expression in Chemotherapy Resistant Ex-vivo Selected "survivor Cells"
  Cell Cycle (Georgetown, Tex.). Dec, 2006  |   Pubmed ID: 17172852
• Mechanisms of Apoptosis Sensitivity and Resistance to the BH3 Mimetic ABT-737 in Acute Myeloid Leukemia
  Cancer Cell. Nov, 2006  |   Pubmed ID: 17097560
• Phase II Study of Low-dose Interleukin-11 in Patients with Myelodysplastic Syndrome
  Leukemia & Lymphoma. Oct, 2006  |   Pubmed ID: 17071475
• Potential Role of Activated Platelets in Homing of Human Endothelial Progenitor Cells to Subendothelial Matrix
  Thrombosis and Haemostasis. Oct, 2006  |   Pubmed ID: 17003929
• 重组人粒细胞-集落刺激因子动员和机采收集的内皮祖细胞： 用于治疗血管发生的新型血液细胞组件。
  Transfusion. Oct, 2006  |   Pubmed ID: 17002637
• Distinct Biological Impact of Dephosphorylation Vs. Downregulation of P210Bcr-Abl: Implications for Imatinib Mesylate Response and Resistance
  Leukemia & Lymphoma. Aug, 2006  |   Pubmed ID: 16966279
• Phase 1/2 Study of the Combination of 5-aza-2'-deoxycytidine with Valproic Acid in Patients with Leukemia
  Blood. Nov, 2006  |   Pubmed ID: 16882711
• Simultaneous Inhibition of PDK1/AKT and Fms-like Tyrosine Kinase 3 Signaling by a Small-molecule KP372-1 Induces Mitochondrial Dysfunction and Apoptosis in Acute Myelogenous Leukemia
  Cancer Research. Apr, 2006  |   Pubmed ID: 16585200
• Triptolide Induces Caspase-dependent Cell Death Mediated Via the Mitochondrial Pathway in Leukemic Cells
  Blood. Jul, 2006  |   Pubmed ID: 16556893
• Plasma Thrombopoietin Compared with Immunoglobulin Heavy-chain Mutation Status As a Predictor of Survival in Chronic Lymphocytic Leukemia
  Blood. Aug, 2006  |   Pubmed ID: 16551975
• Eradication of Leukemia Stem Cells As a New Goal of Therapy in Leukemia
  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Jan, 2006  |   Pubmed ID: 16428470
• Clofarabine and Cytarabine Combination As Induction Therapy for Acute Myeloid Leukemia (AML) in Patients 50 Years of Age or Older
  Blood. Jul, 2006  |   Pubmed ID: 16403905
• The Anti-angiogenesis Agent, AG-013736, Has Minimal Activity in Elderly Patients with Poor Prognosis Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
  Leukemia Research. Jul, 2006  |   Pubmed ID: 16332390
• Pharmacodynamics of Cytarabine Alone and in Combination with 7-hydroxystaurosporine (UCN-01) in AML Blasts in Vitro and During a Clinical Trial
  Blood. Mar, 2006  |   Pubmed ID: 16293603
• Adaphostin-induced Oxidative Stress Overcomes BCR/ABL Mutation-dependent and -independent Imatinib Resistance
  Blood. Mar, 2006  |   Pubmed ID: 16291594
• Z-138 Cell Line Was Derived from a Patient with Blastoid Variant Mantle Cell Lymphoma
  Leukemia Research. Apr, 2006  |   Pubmed ID: 16203034
• OSW-1: a Natural Compound with Potent Anticancer Activity and a Novel Mechanism of Action
  Journal of the National Cancer Institute. Dec, 2005  |   Pubmed ID: 16333034
• WP-1034, a Novel JAK-STAT Inhibitor, with Proapoptotic and Antileukemic Activity in Acute Myeloid Leukemia (AML)
  Anticancer Research. May-Jun, 2005  |   Pubmed ID: 16158916
• Circulating Endothelial Progenitor Cells and Coronary Collaterals in Patients with Non-ST Segment Elevation Myocardial Infarction
  Journal of Vascular Research. Sep-Oct, 2005  |   Pubmed ID: 16088214
• AMN107, a Novel Aminopyrimidine Inhibitor of P190 Bcr-Abl Activation and of in Vitro Proliferation of Philadelphia-positive Acute Lymphoblastic Leukemia Cells
  Cancer. Sep, 2005  |   Pubmed ID: 16078266
• A Novel Ring-substituted Diindolylmethane,1,1-bis[3'-(5-methoxyindolyl)]-1-(p-t-butylphenyl) Methane, Inhibits Extracellular Signal-regulated Kinase Activation and Induces Apoptosis in Acute Myelogenous Leukemia
  Cancer Research. Apr, 2005  |   Pubmed ID: 15805291
• Metastasis--an Alternative Hypothesis
  Cancer. Apr, 2005  |   Pubmed ID: 15739196
• Complex Biallelic IGH Rearrangements in IgM-expressing Z-138 Cell Line: Involvement of Downstream Immunoglobulin Class Switch Recombination
  Genes, Chromosomes & Cancer. Feb, 2005  |   Pubmed ID: 15543623
• Results of a Phase 1-2 Study of Clofarabine in Combination with Cytarabine (ara-C) in Relapsed and Refractory Acute Leukemias
  Blood. Feb, 2005  |   Pubmed ID: 15486072
• Aberrant Morphology, Proliferation, and Apoptosis of B-cell Chronic Lymphocytic Leukemia Cells
  Hematology (Amsterdam, Netherlands). Aug, 2004  |   Pubmed ID: 15621735
• Both Cell Fusion and Transdifferentiation Account for the Transformation of Human Peripheral Blood CD34-positive Cells into Cardiomyocytes in Vivo
  Circulation. Dec, 2004  |   Pubmed ID: 15596566
• The Synthetic Triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic Acid Induces Caspase-dependent and -independent Apoptosis in Acute Myelogenous Leukemia
  Cancer Research. Nov, 2004  |   Pubmed ID: 15520199
• Arsenic Derivatives As Therapeutic Agents for Hematologic Malignancies
  Leukemia Research. Sep, 2004  |   Pubmed ID: 15234564
• Nuclear Factor-kappaB and STAT3 Are Constitutively Active in CD138+ Cells Derived from Multiple Myeloma Patients, and Suppression of These Transcription Factors Leads to Apoptosis
  Blood. Apr, 2004  |   Pubmed ID: 15070700
• Hematopoietic Recovery Following Induction Therapy of Acute Leukemias: Prognostic Implications and a New Look at the Definition of Remission
  Leukemia & Lymphoma. Jan, 2004  |   Pubmed ID: 15061199
• Expression of Constitutively Active Nuclear-kappa B RelA Transcription Factor in Blasts of Acute Myeloid Leukemia
  Human Pathology. Feb, 2004  |   Pubmed ID: 14991544
• Transdifferentiation of Human Peripheral Blood CD34+-enriched Cell Population into Cardiomyocytes, Endothelial Cells, and Smooth Muscle Cells in Vivo
  Circulation. Oct, 2003  |   Pubmed ID: 14568894
• Impact of P210(Bcr-Abl) on Ultraviolet C Wavelength-induced DNA Damage and Repair
  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Sep, 2003  |   Pubmed ID: 14506164
• Adult Stem Cells for Tissue Repair - a New Therapeutic Concept?
  The New England Journal of Medicine. Aug, 2003  |   Pubmed ID: 12904523
• Inhibition of Acute Lymphoblastic and Myeloid Leukemias by a Novel Kinase Inhibitor
  Blood. Dec, 2003  |   Pubmed ID: 12881315
• Increased Apoptosis in Bone Marrow B Lymphocytes but Not T Lymphocytes in Myelodysplastic Syndrome
  Blood. Sep, 2003  |   Pubmed ID: 12730116
• Resveratrol Blocks Interleukin-1beta-induced Activation of the Nuclear Transcription Factor NF-kappaB, Inhibits Proliferation, Causes S-phase Arrest, and Induces Apoptosis of Acute Myeloid Leukemia Cells
  Blood. Aug, 2003  |   Pubmed ID: 12689943
• Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) Induces Antiapoptotic and Proapoptotic Signals in Acute Myeloid Leukemia
  Blood. Jul, 2003  |   Pubmed ID: 12663443
• Commentary: Effect of Flavonoids on Normal and Leukemic Cells
  Leukemia Research. Jun, 2003  |   Pubmed ID: 12648504
• Modulation of Cellular Signaling Pathways: Prospects for Targeted Therapy in Hematological Malignancies
  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Feb, 2003  |   Pubmed ID: 12576416
• N-(4-Hydroxylphenyl)retinamide (fenretinide, 4-HPR), a Retinoid Compound with Antileukemic and Proapoptotic Activity in Acute Lymphoblastic Leukemia (ALL)
  Leukemia Research. Mar, 2003  |   Pubmed ID: 12537979
• Pilot Study of Pegylated Interferon-alpha 2b in Patients with Essential Thrombocythemia
  Cancer Chemotherapy and Pharmacology. Jan, 2003  |   Pubmed ID: 12497210
• The Clinical Significance of Tumor Necrosis Factor-alpha Plasma Level in Patients Having Chronic Lymphocytic Leukemia
  Blood. Aug, 2002  |   Pubmed ID: 12149200
• Reduced Focal Adhesion Kinase and Paxillin Phosphorylation in BCR-ABL-transfected Cells
  Cancer. Jul, 2002  |   Pubmed ID: 12124845
• Time to Platelet Recovery Predicts Outcome of Patients with De Novo Acute Lymphoblastic Leukaemia Who Have Achieved a Complete Remission
  British Journal of Haematology. Jun, 2002  |   Pubmed ID: 12060122
• CD56 Expression Predicts Occurrence of CNS Disease in Acute Lymphoblastic Leukemia
  Leukemia Research. Jul, 2002  |   Pubmed ID: 12008081
• Proliferation and Apoptosis in Acute and Chronic Leukemias and Myelodysplastic Syndrome
  Leukemia Research. Jun, 2002  |   Pubmed ID: 12007503
• Synergistic Induction of Apoptosis by Simultaneous Disruption of the Bcl-2 and MEK/MAPK Pathways in Acute Myelogenous Leukemia
  Blood. May, 2002  |   Pubmed ID: 11964319
• Ex Vivo Expansion of Apheresis-derived Peripheral Blood Hematopoietic Progenitors
  Journal of Clinical Apheresis. 2002  |   Pubmed ID: 11948700
• 肝细胞和上皮细胞的捐助者外周血造血干细胞的起源。
  The New England Journal of Medicine. Mar, 2002  |   Pubmed ID: 11882729
• Cellular Signalling Pathways: New Targets in Leukaemia Therapy
  British Journal of Haematology. Jan, 2002  |   Pubmed ID: 11841398
• Novel Triterpenoid CDDO-Me is a Potent Inducer of Apoptosis and Differentiation in Acute Myelogenous Leukemia
  Blood. Jan, 2002  |   Pubmed ID: 11756188
• Shift of Immunoglobulin Phenotypes in B-cell Precursor Cell Lines
  Leukemia Research. Jan, 2002  |   Pubmed ID: 11734298